2nd booster at 50? Here’s how to decide if you want one: Shots

The FDA has approved double vaccine shots for people over 50 and for some people who are immunocompromised.

Justin Sullivan / photojournalist


hide words

change the caption

Justin Sullivan / photojournalist


The FDA has approved double -blind shots for people over 50 and for some people who are immunocompromised.

Justin Sullivan / photojournalist

Biden’s leadership paved the way for improving COVID immunization for people over 50 and some who were immunocompromised. They can re-order the Moderna or Pfizer-BioNTech booster about four months after their last date.

But since you can get a new booster, is that what you need?

Health officials have disputed the protection provided by the COVID vaccine booster shot at the time. And they are concerned about those who are thought to be at the highest risk of having serious COVID.

But the Centers for Disease Control and Prevention did not explain how quickly people line up for dual stimulants. The agency said the groups were “suitable” for photography but did not say no necessary get them. And some health experts say everyone in this age group doesn’t need a new shot right now.

So, if you’re wondering whether to get a second booster, here are some great reasons to consider.

The risk of serious illness increases with age

The elderly have a serious problem.

A new study found that among people 60 and over had a higher risk of COVID-19 disease and serious illnesses in people with a fourth Pfizer disease compared with three shots. .

“We’re talking about further protection from the most serious impact of COVID,” said Drs. Eric Topol, founder and director of the Scripps Research Translational Institute.

Dr. Bob Wachter, director of the Department of Medicine at the University of California San Francisco, said he personally plans to sign up for a second booster.

“I’m 64 and in good health,” he said. “But it’s clear that six months from my first booster shot, that booster has been a lot less effective.”

He said it would increase the risk of other diseases and reduce the number of diseases. “The benefits are very real,” Wachter said.

But for those under 60, the need for a second booster is unclear.

“I don’t think we have data for young people, 50 to 60,” Drs. Monica Gandhi, is a medical specialist at the University of California, San Francisco. The gift was not included outside of Israel to this young group.

He said other countries were looking for new incentives for the elderly. Germany has allowed a fourth shot for people over 70. The UK is looking for people over 75 and Sweden is giving four shots to people over 80 Gandhi said the US was “flying the gun” by starting with shots for everyone. 50 without relevant information.

The trendline is clear, said Drs. Peter Chin-Hong, is a clinical pathologist at UCSF.

“The older you get, the more fortunate you are,” he said. While the majority of deaths from COVID are over 65, “there is a clear association with age and mortality with COVID,” Chin-Hong said. “It was really amazing and started in the 50s.”

His advice? “Walk to get a second boost if you’re right.” Then he said “go faster and you will be older.” Her mother is in her 80s and she wants to protect her as much as possible. “I’m telling him to go fast,” she said.

Dr. Carlos del Rio, a clinical researcher at Emory University, thinks it’s a good idea for people under 60 to wait. “Medications are well tolerated in chronic illness and death,” he said.

It’s also worth noting that even for people over 60, the added benefit of a new booster shot is very small. Those who received the first booster had a lower rate of death from COVID. Chin-Hong reported Israel learns less than .1% of those with a third gunshot death, a low level he called “amazing.”

Among those who received the fourth of this study only .03% died.

“The magic number is three images, we think, right now,” he said.

The lower levels put you at higher risk

Some medical conditions also increase the risk of morbidity and mortality from COVID-19 and that is why the FDA decided to approve the new drugs starting in the 50s.

“We’ve found that people in the age group range from 50 to 65 – about a third of them have serious illnesses,” Drs. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said at a press conference Tuesday. People with heart disease, neck disease, obesity and diabetes are at higher risk for serious illness and death and those over 50 – more people of color – more of a problem.

“So when choosing someone 50 and older, think about people at a higher level or a higher level,” Marks said. “We thought we would capture the population that would benefit greatly from these four solutions.”

At the age of, “the problem was not resolved,” Wachter said.

The problem may increase, year by year, depending on the age of the person. A 50 -year -old is a lower age than a 65 -year -old, but health status is also relevant.

“A 55 -year -old is less likely to have the same problem as a 65 -year -old who is healthier,” Wachter said.

Bottom line, the problem increases with age and lower levels, and Wachter says many people over 50 benefit from another disease.

“For any serious illness, I like to think about getting a booster,” Drs. Preeti Malani, is a pediatrician at the University of Michigan Health. “For my own family, for my parents and in -laws, this is something I can encourage,” he said. “Because that piece of protection helps verify if they have COVID, it’s a lot easier.”

Immunocompromised patients may need further rehabilitation

Health officials are particularly concerned about immunocompromised people because they respond more quickly to vaccination and are more likely to become ill or die from COVID-19.

That’s why every 12 or more people with certain immunocompromised conditions can get a new shot of Pfizer-BioNTech COVID-19 vaccine, four months after their last disease. A second incentive for fresh corn can be given to people 18 years of age and older.

This applies to people who have changed immunocompromise, or who live with conditions that have a similar level of immunocompromise.

Time from the last illness is important

Evidence is growing that prevention of chronic disease from COVID-19 in the elderly and immunocompromised, is about four to six months earlier than their first booster.

Evidence of decreased immunity from a recent CDC review of COVID-19 emergency room visits and hospital visits during the omicron-predominant period. Two months after the third disease, 91%of patients were discharged from the hospital. But in four months, that barrier had fallen to 78%.

“In other words, those who increased three, four, five, six months ago are not immune to the disease now,” Malani said.

That means a second booster can help counteract that barrier, “but it won’t last long.” So the timing of the next shot can be difficult.

Now the number of illnesses has dropped significantly since the January rise, but there are signs that illnesses are on the rise in some areas. The omicron difference is more BA.2 infection is now prevalent in the US, and hospitalizations are rampant in some areas.

Peter Chin-Hong said some people may want to wait to get a booster until issues start to escalate in their community and they want more protection.

He also realized that there were probably better medicines in the air. Cannabis manufacturers are experimenting with omicron-specific drugs and continue to research drugs that can prevent a variety of conditions, making it better for people with low blood pressure to wait.

But if you’re having a hard time, you probably don’t want to wait too long. Polls show that many people were diagnosed with booster disease first when they were diagnosed last year. But waiting until you see a new disease in your community can be difficult.

“It reminds me a little bit of trying it out during the stock market. If you have a disease on the side, it’s better to increase your immunity than that.

There is one more thing to consider when deciding the timing of a fourth illness: Have you had a new COVID-19 infection? If you get three shots and you get an omicron infection sometime between December and now, “I think it’s worth the wait.” Wachter’s place. He said a new disease would put a person in an immunologic condition similar to a second booster.

Rob Stein gave this presentation.

Related Posts

Leave a Reply

Your email address will not be published.